Tayyaba Iqbal

Efficacy of and Safety of Secukinumab in Psoriasis Vulgaris: A Prospective Study

Syeda Shahmoona Tirmizi, Tayyaba Iqbal, Saher Ather, Nadia Farooq, Maria Mansoor, Marium Asar, Naseema Kapadia & Qurrat Ul Ain · Journal of Pharmaceutical Research International · 2022

Objective: Psoriasis is an immune mediated inflammatory skin disorder that potentially requires lifelong management. Different therapies treating psoriasis have been recognized wherein Secukinumab is a fully humanized, IL-17A monoclonal antibody that has been approved by US Food...

Open access Research Article 10.9734/jpri/2022/v34i35A36164

Dermatophytosis: An Epidemiological Study in a Tertiary Care Center in Rural Sind

Shazia Bano, Kousar Parveen, Hafiz Bashir Ahmed, Sikandar Ali Sial, Tayyaba Iqbal & Amir Bux Detho · Journal of Pharmaceutical Research International · 2021

Aims and Objects: Dermatophytosis is a common infection worldwide, and a major public health issue. Hot, humid climates and overcrowding favor the spread of skin infection in general populations. The purpose of the study is to analyze the prevalence of disease in patients attendi...

Open access Research Article 10.9734/jpri/2021/v33i62A35159